About Evoluent Pharmaceuticals Private Limited
Data last updated:
Evoluent Pharmaceuticals Private Limited is a private limited company based in Palace Guttahalli, Karnataka, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 29 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC083741. Its GSTIN is 29AAECE0979R1ZR (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Belavanur Rudrappa Manjunathappa and Ranganathaiah Chethan.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at No 01 Nagappa Street Vinayaka Circle 2nd Main Road, Palace Guttahalli, Karnataka, India – 560003.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.41 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net profit of ₹1,314 (net margin 0.5%) and EBITDA of ₹16,069 (EBITDA margin 6.7%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evoluentpharma.com.
Company details
Contact details
Evoluent Pharmaceuticals Private Limited's registered office is in Palace Guttahalli, Karnataka. Its website is evoluentpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo 01 Nagappa Street Vinayaka Circle 2nd Main Road, Palace Guttahalli, Karnataka, India – 560003
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Evoluent Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Evoluent Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Evoluent Pharmaceuticals Private Limited, buy the company report.
Financials of Evoluent Pharmaceuticals Private Limited
FY 2021 filings availableEvoluent Pharmaceuticals Private Limited reported revenue of ₹2.41 Lakh (down 55% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 38% over three years, including a 55% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16,069 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,314 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evoluent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Evoluent Pharmaceuticals Private Limited
Evoluent Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranganathaiah Chethan | Additional Director | 11 Feb 2019 | 7 Years 8 Months | Current |
| Belavanur Rudrappa Manjunathappa | Director | 29 Oct 2015 | 10 Years 11 Months | Current |
| Priyanka Kotrappa | Additional Director | 23 Nov 2017 | 8 Years 10 Months | Current |
Peer comparison
Evoluent Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Albert Pharmaceuticals Private Limited | ₹2.43 Lakh (FY 2021) | -49.0% | Gopalganj, Bihar, India | |||
| Emblem Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2025) | -58.0% | Delhi, India | |||
| Evoluent Pharmaceuticals Private Limited this company | ₹2.41 Lakh (FY 2021) | ₹1,314 | 0.5% | -55.0% | Palace Guttahalli, Karnataka, India | |
| Omish Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2023) | -93.0% | Delhi, India | |||
| Ambajee Druggists Private Limited | ₹2.4 Lakh (FY 2025) | -98.0% | New Delhi, Delhi, India | |||
| Valtin Healthcare Private Limited | ₹2.38 Lakh (FY 2018) | New Delhi, Delhi, India |
To see the full peer comparison of Evoluent Pharmaceuticals Private Limited, buy the company report.
Auditor
Evoluent Pharmaceuticals Private Limited is audited by M LAKSHMINARASAIAH for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M LAKSHMINARASAIAH | FY 2017 | 022884 |
Shareholding
The shareholding of Evoluent Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Evoluent Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Evoluent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evoluent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Evoluent Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECE0979R1ZR | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Evoluent Pharmaceuticals Private Limited, buy the company report.
Recent activity
Evoluent Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Ranganathaiah Chethan was appointed as Additional Director on 11 Feb 2019.
Frequently asked questions
Evoluent Pharmaceuticals is an active private limited company based in Palace Guttahalli, Karnataka, India. The company works in retailers, within the trading industry. It was incorporated on 29 October 2015 (11+ years old) and is registered under CIN U24230KA2015PTC083741.
Evoluent Pharmaceuticals has 3 current directors:
- Ranganathaiah Chethan - Additional Director
- Belavanur Rudrappa Manjunathappa - Director
- Priyanka Kotrappa - Additional Director
The latest financial statements of Evoluent Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Evoluent Pharmaceuticals is 29AAECE0979R1ZR, registered in Karnataka.
The CIN (Corporate Identification Number) of Evoluent Pharmaceuticals is U24230KA2015PTC083741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evoluent Pharmaceuticals was incorporated on 29 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Evoluent Pharmaceuticals by revenue are Albert Pharmaceuticals Private Limited, Emblem Pharmaceuticals Private Limited, Omish Pharmaceuticals Private Limited, Ambajee Druggists Private Limited, Valtin Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ranganathaiah Chethan was appointed as Additional Director on 11 Feb 2019. Priyanka Kotrappa was appointed as Additional Director on 23 Nov 2017. Suresh Gowda ceased to be Director on 23 Nov 2017. Evoluent Pharmaceuticals has 4 board changes on record in total.
Evoluent Pharmaceuticals can be reached through the website evoluentpharma.com. Its registered office is in Palace Guttahalli, Karnataka, India.
The registered office of Evoluent Pharmaceuticals is at No 01 Nagappa Street Vinayaka Circle 2nd Main Road, Palace Guttahalli, Karnataka, India – 560003.
Evoluent Pharmaceuticals operates in the trading industry, in the retailers segment.